He is now on day #9 of 10 of the Ceftriaxone for his positive BAL for Serratia and his secretions have greatly decreased and the patient's oxygen requirement has also greatly decreased.
For aspiration, the patient has had a swallow study on [**2113-11-10**] which he did not pass due to silent aspirations.
The patient also had an echocardiogram on [**2113-11-10**] which revealed a moderately dilated left atrium, moderately dilated right atrium and normal left ventricular function with an left ventricular ejection fraction of 50 to 55%, normal right ventricle, aortic valve leaflets, mildly thickened, no aortic regurgitation, a bioprosthetic mitral valve with no mitral regurgitation and tricuspid valve leaflets mildly thickened, valve annuloplasty ring present, moderate 2+ tricuspid regurgitation.
Note: patient has mosaic bioprosthetic MVR which does not require longterm anticoagulation.
